SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005857
Filing Date
2016-05-11
Accepted
2016-05-11 09:01:50
Documents
64
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acrs-20160331x10q.htm 10-Q 1083903
2 EX-2.1 acrs-20160331ex21d2988dc.htm EX-2.1 571933
3 EX-10.1 acrs-20160331ex1016acb79.htm EX-10.1 310909
4 EX-10.2 acrs-20160331ex1027431d6.htm EX-10.2 27553
5 EX-10.3 acrs-20160331ex1030a0b9b.htm EX-10.3 27489
6 EX-10.4 acrs-20160331ex104c88ab0.htm EX-10.4 26485
7 EX-10.5 acrs-20160331ex1057aba78.htm EX-10.5 42877
8 EX-31.1 acrs-20160331ex311a7c183.htm EX-31.1 14055
9 EX-31.2 acrs-20160331ex3124fefdf.htm EX-31.2 14041
10 EX-32.1 acrs-20160331ex3214543ef.htm EX-32.1 10510
  Complete submission text file 0001558370-16-005857.txt   5810301

Data Files

Seq Description Document Type Size
11 EX-101.INS acrs-20160331.xml EX-101.INS 1071789
12 EX-101.SCH acrs-20160331.xsd EX-101.SCH 32669
13 EX-101.CAL acrs-20160331_cal.xml EX-101.CAL 37885
14 EX-101.DEF acrs-20160331_def.xml EX-101.DEF 122302
15 EX-101.LAB acrs-20160331_lab.xml EX-101.LAB 352915
16 EX-101.PRE acrs-20160331_pre.xml EX-101.PRE 248894
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37581 | Film No.: 161638205
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences